![Allison Dorval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allison Dorval
Direktor/Vorstandsmitglied bei
PUMA BIOTECHNOLOGY, INC.
Vermögen: 540 546 $ am 31.05.2026
Profil
Allison Dorval is currently an Independent Director at Puma Biotechnology, Inc. since 2021.
Former positions include Independent Director at Jade Biosciences, Inc. from 2021 to 2025; Vice President & Controller at Catalent JNP, Inc. from 2016 to 2017; Chief Financial Officer at Arsenal Medical, Inc. from 2015 to 2016; Chief Financial Officer at Lyra Therapeutics, Inc. from 2015 to 2016; Chief Financial Officer at Insulet Corp.
from 2014 to 2015; Chief Financial & Accounting Officer at Verve Therapeutics, Inc. from 2021 to 2025; Chief Financial Officer at Voyager Therapeutics, Inc. from 2018 to 2021; Finance Director at Digitas, Inc.; Assistant Controller at iBASIS, Inc.; and Principal at PricewaterhouseCoopers LLP.
Education includes undergraduate studies at the University of Vermont.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,15 % | 13.04.2026 | 75 390 ( 0,15 % ) | 540 546 $ | 31.05.2026 |
Aktive Positionen von Allison Dorval
| Unternehmen | Position | Beginn |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 15.07.2021 |
Ehemalige bekannte Positionen von Allison Dorval
| Unternehmen | Position | Ende |
|---|---|---|
| VERE THER | Finanzdirektor/CFO | 25.07.2025 |
| JADE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
| VOYAGER THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2021 |
| JUNIPER PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.06.2017 |
| LYRA THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.08.2016 |
Ausbildung von Allison Dorval
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
iBASIS, Inc.
 iBASIS, Inc. Specialty TelecommunicationsCommunications Provides voice, mobile, messaging, IoT and cloud solutions | Communications |
Digitas, Inc.
 Digitas, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital and interactive marketing services | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
